Member Info for CityWatcher

Proposing a 3.81p dividend at their approaching meeting, plus results read very bullish, especially like the following too. ...

GB Group plc (AIM: GBG), the experts in digital location, identity verification and fraud software, today announces the appointment of Barclays Bank plc ('Barclays') and Numis Securities Limited ('Numis') as Joint Corporate Brokers. Numis has also been appointed as Nominated Adviser to the Company with immediate effect.

Whoopee ! A Blue Day is Forecast for GDR. About time eh !

Upped his stake as he can't see them dropping much lower, maybe. Also is there a dividend going to be paid in the next couple of months ? Company is bullish for the future too.

In CITYA.M. ' The wargaming specialist should ride the pandemic wave and remain resilient to easing restrictions. Also expected to be resistant to any future recession this year. Also being in a ''strong position'' so has considerable opportunity to grow in North America & largely untapped potential in Asia, and so has kept it's buy stance. Peel Hunt also expects full year profits before tax to reach at least £155m.'
So I say roll on those results near middle July.

I'm surprised it's dropped as much as 7% today considering the broker's reiteration on a high target price.

10-Jun-22 Eco (Atlantic) (ECO) Berenberg Bank Buy 125.00 125.00 Reiteration

They have nearly halved their stake & are down to 3.6% , so perhaps they don't approve the Tullow deal that is on offer.

There may be some more selling & ASOS is going to be a bargain then. But Barclays don't believe they are that profitable to invest in as they have lowered their target price, although another broker is still bullish.

01-Jun-22 Barclays Equal-weight 2,125.00 1,615.00 Reiteration

Just a waiting game now. They said a temporary suspension. Noticed the share was up slightly yesterday too.

Too many cannabis farms is what you reckon then.

The market conditions have been bumpy & I sold out too early yesterday. Happy to reinvest elsewhere & anyone else who might have missed any further rise should also have plans. But perhaps not Tullow.

"We are very pleased to announce these drilling results which have produced lithium grades surpassing our expectations and reinforce our belief that Uis is host to one of the largest lithium resources globally. While the V1/V2 pegmatite displays impressive dimensions and is open-ended at depth, a multitude of surrounding pegmatites present significant upside potential."

Reckon as this has continued it's climb upwards on a poor market day. Just had to sell out Solgold & buy some more Pure.
Other's seem to have thought the same towards close. Great share to invest in following those director purchases.

I'm looking at a decent profit now as they are close to the tender price. Held all then as not invested enough in Cairn Energy. Mulling over whether to sell & perhaps follow your advice or even use the money elsewhere. See there have been some big sales today i.e. pooling in £1m. Tullow still tending to drop is also concerning me.

Great news, especially after those awesome director buys. Have to be in the know eh !

Covid test success likely here. But GDR should prove profitable also as their hearing loss tests for babies is a great invention too. Note the too !!

Worth a read to decide whether an investment here is worthwhile. Perhaps another strong buy for recovery.

Chris Yates, CEO of Abingdon Health plc, commented: "We are delighted to have secured such a significant agreement with Arise Biotech for the supply of Abingdon Simply Test COVID-19 tests for Taiwan. We must be clear with investors that fulfilment of this order depends on the successful completion of the Taiwan EUA application process, and we will update investors as soon as we can on this."

Recovery buy for ABDX on their announced news today. Genedrive investors, come on you know it makes sense to diversify. Buy on any dips on the day if possible methinks.

Chris Yates, CEO of Abingdon Health plc, commented: "We are delighted to have secured such a significant agreement with Arise Biotech for the supply of Abingdon Simply Test COVID-19 tests for Taiwan. We must be clear with investors that fulfilment of this order depends on the successful completion of the Taiwan EUA application process, and we will update investors as soon as we can on this."

Samuel Chou, Chairman of Arise Corporation, commented: "We are greatly blessed with the opportunity to work with Abingdon Health, on our mission for global equitable access to diagnostics. May this project be yet another testimony of God's grace."

Buying Clontarf is maybe for the brave right now, or is it for some wise investors. Can't decide.

Genedrive's product for babies hearing assistance checks should also boost this share upwards remember. Today's news is also very positive .

I say sell soon owing to the major rise being factored into the dividend ( goes ex 1st July approx 9p) & the special dividend if passed at their meeting (goes ex 15th July approx 18p). Profit taking is bound to occur soon rather than sit tight to qualify for the dividends ( 27p total approx.) So might be wise to sell a chunk if the price climbs to £3 -20 say. But it may not get there !!